Coronary artery disease locus 1p32.2 and miR92a-PPAP2B signaling in endothelial mechanobiology
内皮力学生物学中的冠状动脉疾病基因座 1p32.2 和 miR92a-PPAP2B 信号传导
基本信息
- 批准号:10171493
- 负责人:
- 金额:$ 39.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-10 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAffectAllelesAllelic ImbalanceAmericanApolipoprotein EArterial Fatty StreakArteriesArtificial nanoparticlesAtherosclerosisBindingBiological AssayBiologyBlood VesselsBlood flowCardiovascular DiseasesComplementary DNACoronary ArteriosclerosisDiseaseDisease susceptibilityEMSAEndothelial CellsEndotheliumEnhancersGenesGenetic DiseasesGenetic Predisposition to DiseaseGenetic VariationGoalsHumanIn VitroInflammationIntronsInvestigationLesionLinkMechanicsMediatingMicroRNAsMolecularMorbidity - disease rateMusMyocardial InfarctionPathway interactionsPharmacologyPhenotypePhosphatidate PhosphataseQuantitative Trait LociRegulationRiskRoleSignal TransductionSiteStimulusStrokeTestingTissuesTransgenic MiceVascular Endotheliumathero susceptibleatherogenesiscausal variantchromosome conformation capturegenetic approachgenome editinggenome wide association studyhuman tissuein vivoin vivo evaluationinhibitor/antagonistinnovationinsightmechanotransductionmonolayermortalitymouse modelnanoparticleprotective allelerisk variantselective expressiontranscription factor
项目摘要
Project Summary
Atherosclerotic arterial disease remains the leading cause of morbidity and mortality among Americans.
Atherosclerosis preferentially develops in arterial sites such as curvatures and bifurcations, where endothelial
cells are activated by local disturbed flow. Recent studies have suggested new genes and previously unsus-
pected biology that mechanistically contribute to atherosclerosis; however, the interplay between genetic pre-
disposition of atherosclerosis and flow-mediated endothelial functions remains to be elucidated.
Genome-wide association studies (GWAS) and subsequent investigations identified PhosPhatidic-Acid-
Phosphatase-type-2B (PPAP2B, also known as LPP3 or PLPP3) as a gene at chr 1p32.2 that significantly
influences risk of coronary artery disease (CAD). Moreover, reduced endothelial PPAP2B is associated with
increased CAD susceptibility. We recently discovered a new mechanism that links disturbed flow to reduction
in endothelial PPAP2B through a microRNA-mediated mechano-transduction pathway: disturbed flow activates
endothelial miR-92a, which in turn suppresses PPAP2B directly and also indirectly by inhibiting the
transcription factor KLF2 that activates PPAP2B; reduced endothelial PPAP2B then leads to increased
endothelial inflammation and compromised monolayer integrity. Furthermore, previous studies showed that
systemic delivery of miR-92a inhibitor suppressed miR-92a in a wide range of tissues and lessened
atherosclerosis in mice. Although these results suggest that flow-sensitive miR92a-PPAP2B pathway
contributes to the athero-susceptible endothelial phenotype, the potentially causal relationship between
endothelial miR92a-PPAP2B pathway and atherogenesis in vivo remains uncertain. Moreover, the mechanism
by which the CAD-associated causal variant in PPAP2B exerts its effect and its potential roles in endothelial
mechano-transduction remains unexplored.
We have gathered very strong evidence that PPAP2B genetic variation interacts with unidirectional
flow in concert to promote endothelial PPAP2B. The overall goal is to elucidate the molecular convergence of
CAD genetic predisposition and mechano-transduction mechanisms in the endothelial miR92a-PPAP2B path-
way, dysregulation of which is hypothesized to causatively promote atherosclerosis. Our proposed studies ad-
dress three questions of fundamental importance: 1) Does the endothelial miR92a-PPAP2B pathway causally
regulate atherosclerosis in vivo? We test this in Aim 1 with new mouse models and innovative nanoparticles to
selectively modulate endothelial miR92a-PPAP2B signaling. 2) How does the CAD protective allele at
rs17114036 influence PPAP2B expression? In Aim 2, we functionally characterize the rs17114036-depedent
enhancer in PPAP2B employing complementary in vivo and in vitro genetic approaches. 3) What is the addi-
tional role of KLF2 in regulating allele-specific PPAP2B expression? We address the dynamic regulation of this
rs17114036-containing enhancer by mechanical and pharmacological stimuli via KLF2 in Aim 3.
项目摘要
动脉粥样硬化性疾病仍然是美国人发病率和死亡率的主要原因。
动脉粥样硬化优先发生在动脉部位,如弯曲和分叉,其中内皮细胞
细胞被局部扰动流激活。最近的研究表明,新的基因和以前不一致的-
预期的生物学机制有助于动脉粥样硬化;然而,遗传前,
动脉粥样硬化的分布和血流介导的内皮功能仍有待阐明。
全基因组关联研究(GWAS)和随后的调查发现,
磷酸酶2B型(PPAP 2B,也称为LPP 3或PLPP 3)作为chr 1p32.2的基因,
影响冠状动脉疾病(CAD)的风险。此外,内皮PPAP 2B减少与
增加CAD易感性。我们最近发现了一种新的机制,将扰动流与还原联系起来
通过microRNA介导的机械转导途径在内皮PPAP 2B中:扰动流动激活
内皮细胞miR-92 a,其反过来直接抑制PPAP 2B,也通过抑制内皮细胞miR-92 a间接抑制PPAP 2B。
激活PPAP 2B的转录因子KLF 2;减少内皮PPAP 2B然后导致增加
内皮炎症和受损的单层完整性。此外,先前的研究表明,
miR-92 a抑制剂的全身递送在广泛的组织中抑制miR-92 a,并且减少了miR-92 a抑制剂的全身递送。
小鼠动脉粥样硬化。尽管这些结果表明,流动敏感的miR 92 a-PPAP 2B途径
导致动脉粥样硬化易感的内皮细胞表型,
内皮miR 92 a-PPAP 2B途径和动脉粥样硬化形成的体内研究仍不确定。此外,该机制
PPAP 2B中CAD相关的因果变异体通过其发挥作用及其在内皮细胞中的潜在作用。
机械转导仍然未被探索。
我们已经收集了非常强有力的证据,PPAP 2B基因变异与单向
流动一致地促进内皮PPAP 2B。总的目标是阐明的分子收敛
内皮miR 92 a-PPAP 2B通路中的CAD遗传易感性和机械转导机制-
的方式,其失调被假设为促进动脉粥样硬化的原因。我们建议的研究-
阐述了三个基本重要的问题:1)内皮miR 92 a-PPAP 2B途径是否与内皮细胞的增殖有关?
调节体内动脉粥样硬化?我们在Aim 1中使用新的小鼠模型和创新的纳米颗粒来测试这一点,
选择性地调节内皮miR 92 a-PPAP 2B信号传导。2)CAD保护性等位基因在
rs 17114036影响PPAP 2B表达?在目标2中,我们功能性地描述了rs 17114036依赖的
在PPAP 2B增强子中使用互补的体内和体外遗传方法。3)什么是附加-
KLF 2在调节等位基因特异性PPAP 2B表达中的作用?我们解决这个动态调节
目的3中通过KLF 2的机械和药理学刺激来增强含有rs 17114036的增强子。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Targeting mechanosensitive endothelial TXNDC5 to stabilize eNOS and reduce atherosclerosis in vivo.
- DOI:10.1126/sciadv.abl8096
- 发表时间:2022-01-21
- 期刊:
- 影响因子:13.6
- 作者:Yeh CF;Cheng SH;Lin YS;Shentu TP;Huang RT;Zhu J;Chen YT;Kumar S;Lin MS;Kao HL;Huang PH;Roselló-Sastre E;Garcia F;Jo H;Fang Y;Yang KC
- 通讯作者:Yang KC
The Runt of the Litter-Stronger than We Thought?
幼崽中的弱者——比我们想象的更强?
- DOI:10.1165/rcmb.2017-0059ed
- 发表时间:2017
- 期刊:
- 影响因子:6.4
- 作者:Fang,Yun;Davis,IanC
- 通讯作者:Davis,IanC
Mechanosensitive super-enhancers regulate genes linked to atherosclerosis in endothelial cells.
- DOI:10.1083/jcb.202211125
- 发表时间:2024-03-04
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mechanical forces and metabolic changes cooperate to drive cellular memory and endothelial phenotypes.
- DOI:10.1016/bs.ctm.2021.07.003
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Li J;Fang Y;Wu D
- 通讯作者:Wu D
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yun Fang其他文献
Yun Fang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yun Fang', 18)}}的其他基金
Precision nanomedicine targeting novel endothelial mechano-sensing mechanisms
针对新型内皮机械传感机制的精密纳米医学
- 批准号:
10630052 - 财政年份:2022
- 资助金额:
$ 39.9万 - 项目类别:
Precision nanomedicine targeting novel endothelial mechano-sensing mechanisms
针对新型内皮机械传感机制的精密纳米医学
- 批准号:
10354607 - 财政年份:2022
- 资助金额:
$ 39.9万 - 项目类别:
Spatial Delivery of MicroRNA Inhibitor via Targeted Polyelectrolyte Complex Micelles to Treat Atherosclerosis.
通过靶向聚电解质复合胶束空间递送 MicroRNA 抑制剂来治疗动脉粥样硬化。
- 批准号:
10229491 - 财政年份:2017
- 资助金额:
$ 39.9万 - 项目类别:
Coronary artery disease locus 1p32.2 and miR92a-PPAP2B signaling in endothelial mechanobiology
内皮力学生物学中的冠状动脉疾病基因座 1p32.2 和 miR92a-PPAP2B 信号传导
- 批准号:
9539874 - 财政年份:2017
- 资助金额:
$ 39.9万 - 项目类别:
Spatial Delivery of MicroRNA Inhibitor via Targeted Polyelectrolyte Complex Micelles to Treat Atherosclerosis.
通过靶向聚电解质复合胶束空间递送 MicroRNA 抑制剂来治疗动脉粥样硬化。
- 批准号:
10004707 - 财政年份:2017
- 资助金额:
$ 39.9万 - 项目类别:
miR-10a regulation of regional arterial endothelial phenotypes in atherosclerosis
miR-10a对动脉粥样硬化区域动脉内皮表型的调节
- 批准号:
8639625 - 财政年份:2013
- 资助金额:
$ 39.9万 - 项目类别:
miR-10a regulation of regional arterial endothelial phenotypes in atherosclerosis
miR-10a对动脉粥样硬化区域动脉内皮表型的调节
- 批准号:
8653985 - 财政年份:2013
- 资助金额:
$ 39.9万 - 项目类别:
miR-10a regulation of regional arterial endothelial phenotypes in atherosclerosis
miR-10a对动脉粥样硬化区域动脉内皮表型的调节
- 批准号:
8247722 - 财政年份:2011
- 资助金额:
$ 39.9万 - 项目类别:
miR-10a regulation of regional arterial endothelial phenotypes in atherosclerosis
miR-10a对动脉粥样硬化区域动脉内皮表型的调节
- 批准号:
8111489 - 财政年份:2011
- 资助金额:
$ 39.9万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 39.9万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 39.9万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 39.9万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 39.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 39.9万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 39.9万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 39.9万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 39.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 39.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 39.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




